Improving Treatment in Children with Community-Acquired Pneumonia with Atypical Etiology

Resumen

Improving the tactics of treating pneumonia is one of the most urgent problems of modern pediatrics. We conducted a survey of 120 sick children with community-acquired pneumonia aged 6 months to 14 years, divided into 2 groups: group I - 30 patients with mycoplasma and 30 with chlamydial etiology, who received standard therapy, group II - 30 patients with mycoplasma and 30 patients with chlamydial etiology who received josamycin and resistol in the complex of standard therapy. Josamycin was administered at 50 mg/kg in 2-3 doses per day orally, Resistol for children from 1 year to 6 years 10 drops 3 times a day, from 6 to 12 years 20 drops 3 times a day. The drugs were used throughout the course of treatment.